ABSTRACT Treatment of young and mature mice with potent mouse, interferon preparations results in a marked enhancement of the expression of histocompatibility antigens on the surface of thymocytes and splenic lymphocytes as measured by an enhanced absorption of alloantiserum. We postulate that such modifications of the cell surface may reilect an effect of interferon on lymphocyte maturation and may be relevant to the effect of interferon on lymphocyte function.
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Since interferon can affect both the division and function of lymphocytes (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) it seems likely that it plays a role in the regulation of the humoral (6-11) and cell-mediated immune response (1, 2, (12) (13) (14) (15) (16) (17) . We have recently shown that incubation of mouse lymphoid cells with interferon was accompanied by a marked enhancement of the expression of surface histocompatibility antigens (18) . The availability of potent semi-purified mouse interferon preparations (19) enabled us to determine whether treatment of mice with interferon would also result in modifications in the expression of histocompatibility antigens on thymocytes and splenic lymphocytes. The results of these experiments are presented herein.
MATERIALS AND METHODS
Mice. DBA/2 mice were obtained from the breeding colony of the Institut du Cancer. Interferon and Control Preparations. Mouse interferon was prepared from mouse C-243 cells (20) cultivated in suspension culture and infected with Newcastle disease virus (NDV) (19) . After concentration and partial purification by selective precipitation with ammonium sulfate (19) ' As can be seen from Fig. 2A and B there was little variation between the curves of alloantibody absorption for splenic lymphocytes from individual mice within each group. A significant difference in the alloantibody absorption was observed, however, between mice treated with interferon and those treated with a control preparation.
Relation between amount of interferon injected and enhancement of expression of histocompatibility antigens on splenic lymphocytes
The results of some experiments indicated that a single injection of an interferon preparation titering 10-6 into young mice (24 or 48 hr before sacrifice) would result in some increase in the antibody-absorbing capacity of thymocytes and splenic lymphocytes. A consistent and marked enhancement was, however, always observed when mice were injected four times during a 48 hr period. Accordingly, in the following experiment 17-day-old mice were injected four times i.p. with 0.25 ml of 10-fold dilutions of an interferon preparation and sacrificed 48 hr after the beginning of the injections. As can be seen in Fig. 3 the splenic lymphocytes of mice receiving injections of an interferon preparation titering 10-6 or 10-5 showed an enhanced absorption of alloantiserum, whereas no effect was observed in mice injected with the more dilute interferon preparations.
Evidence that interferon is responsible for enhanced absorption of alloantibody Use of Heterologous and Inactivated Homologous Interferon Preparations. Two-week-old DBA/2 mice from three litters were distributed into six groups and treated (0.25 ml injected i.p. four times at 12 hr intervals) as follows (three mice in each group): (1) a mouse interferon preparation titering 1.6 X 10-6; (2) the same preparation inactivated by incubation with crystalline trypsin (500,gg/ml at 370 for 1 hr) and having a residual titer of 1 X 10-1; (3) a mock interferon preparation demonstrating no antiviral activity at a 1:5 dilution; (4) the same mock interferon preparation pretreated with trypsin (as in group 2); (5) a human leukocyte interferon preparation having a titer of 1.6 X 10-6 on human fibroblasts and 8 X 10-1 on mouse L cells; and (6) no treatment.
As can be seen in Fig. 4 In other experiments mice were injected with 10-fold dilutions of NDV and the serum interferon levels were determined for each group. A slight but still significant increase in the absorption of alloantiserum was observed for splenic lymphocytes and thymocytes from mice injected with 106 TCID5o of NDV. The serum interferon titer in these mice was 1:320 at 6 hr.
(n_ A comparison of the effect of cortisone and interferon on the expression of histocompatibility antigens on splenic lymphocytes and thymocytes It has been shown that cortisone treatment of mice is accompanied by a marked loss of thymocytes and the preservation within the thymus of a cell population which expresses histocompatibility antigens strongly (22, 23) . Therefore, it was considered of interest to compare the effect of interferon on the expression of histocompatibility antigens on lymphoid cells with that induced by cortisone. Four 7-week-old DBA/2 male and female mice were injected ip. four times at 12 hr intervals with 0.25 ml of an interferon preparation titering 1.6 X 10-6. At the.time of the first interferon injection another group of nine mice was injected once iLp. with cortisone acetate (375 mg/kg of body weight). It was necessary to inject nine mice with cortisone to obtain sufficient number of cells from the thymuses. Four mice were left untreated. Forty-eight hours after the first injection all mice were sacrificed and the spleens or thymuses from mice in each group were pooled.
As can be seen from Fig. 6 , thymocytes from both interferon-and cortisone-treated mice exhibited an enhanced absorption of alloantiserum. Splenic lymphocytes from interferon-treated mice showed an enhanced absorption of alloantiserum, whereas no significant effect was observed for splenic lymphocytes from cortisone-treated mice. (In a second experiment splenic lymphocytes from cortisone-treated mice appeared to exhibit a slightly decreased absorbing capacity.) Also, interferon treatment of mice did not significantly affect the total. cell number in thymus and spleen, whereas cortisone treatment was accompanied by a marked loss of cells in both organs (Table 1) Four 6-week-old DBA/2 mice were injected i.p. four times at 12 hr intervals with 0.25 ml of an interferon preparation titering 1.6 X 10-6. Four mice were left untreated and four mice were injected once i.p. with cortisone acetate (375 mg/kg of body weight). All mice were sacrificed 48 hr after the first injection and cell counts were performed on cell suspensions from thymus and spleen by the trypan blue dye exclusion method.
young (2-3 week old) and mature (6-8 week old) DBA/2 mice with potent mouse interferon preparations is accompanied by an enhanced expression of histocompatibility antigens on the surface of thymocytes and splenic lymphocytes as measured by an enhanced absorption of alloantiserum. Although pure interferon is not available, the evidence presented above and as discussed in our previous reports (1, 2, 14, 18, 21) strongly suggests that interferon is the factor responsible for this phenomenon.
Two possibilities may be suggested to explain the increased expression of H-2 antigens on thymocytes from interferon-treated mice. First: like cortisone treatment, interferon treatment might result in the loss of a thymic cell population which expresses H-2 antigen poorly. The remaining cells might, like cortisone-resistant thymocytes, express H-2 antigens strongly. However, since interferon treatment did not result in a significant decrease in the number of thymocytes, but did induce a marked enhancement in the expression of H-2 antigens (comparable to that observed for cortisone-treated mice- Fig. 6 , Table 1 ), this explanation seems unlikely. Second: interferon treatment may result in a general increase in the expression of H-2 antigens on thymocytes. Since our previous results from in vitro experiments suggested that the effect of interferon on the expression of H-2 antigens on cortisone-resistant thymocytes was not very pronounced (18), we suggest that interferon treatment of mice is accompanied by a general enhancement of the expression of H-2 antigens but that this effect is most pronounced on those thymic cells which normally express H-2 antigens poorly. These cells are considered to represent the majority of "immature" thymocytes (23) .
In contrast to cortisone, interferon treatment of young and adult mice also resulted in an increased expression of H-2 antigens on splenic lymphocytes (Fig. 6) . We had previously observed that interferon treatment of spleen cells in vitro was accompanied by an enhanced expression of H-2 antigens on splenic lymphocytes from young, but not from mature mice (18) . We do not at present have a satisfactory explanation for this apparent difference between our present in vivo and previous in vitro results as pertains to the effect of interferon on splenic lymphocytes from mature mice.
Since we are not aware of any other substance that enhances the expression of cell surface histocompatibility antigens in vivo and since the biologic role of these antigens themselves is unknown, it is difficult to speculate at present on the significance of our observations. Furthermore, we do not yet know whether interferon can modify the expression of other surface antigens on lymphoid cells. Although our previous results from in vitro experiments showed that interferon did not affect the expression of the theta antigen on thymocytes and splenic lymphocytes (18) , it will be of interest to determine its effect on the expression of those lymphocyte markers that vary with the stage of lymphocyte maturation, i.e., TL antigens (24 
